imipramine and antimony

imipramine has been researched along with antimony in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Das, AK; Dujardin, JC; Mukherjee, B; Mukherjee, S; Mukhopadhyay, R; Naskar, K; Roy, S; Sundar, S	1
Dujardin, JC; Mukherjee, B; Mukherjee, S; Mukhopadhyay, R; Naskar, K; Roy, S; Sundar, S	1

Other Studies

2 other study(ies) available for imipramine and antimony

Article	Year
Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection. PLoS neglected tropical diseases, 2012, Volume: 6, Issue:12 Topics: Administration, Oral; Animals; Antimony; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Drug Resistance; Imipramine; Leishmania donovani; Leishmaniasis, Visceral; Parasitic Sensitivity Tests; Treatment Outcome	2012
Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection. Journal of immunology (Baltimore, Md. : 1950), 2014, Oct-15, Volume: 193, Issue:8 Topics: Acetylation; Animals; Antibodies; Antimony; Antimony Sodium Gluconate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Cricetinae; Drug Resistance; Histone Deacetylase 6; Histone Deacetylases; Imipramine; Interleukin-10; Interleukin-12; Interleukin-12 Subunit p35; Interleukin-12 Subunit p40; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; NF-kappa B p50 Subunit; Promoter Regions, Genetic; Signal Transduction; T-Lymphocytes; Transcription Factor RelA; Trypanocidal Agents	2014

Article

Year

Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection.

PLoS neglected tropical diseases, 2012, Volume: 6, Issue:12

Topics: Administration, Oral; Animals; Antimony; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Drug Resistance; Imipramine; Leishmania donovani; Leishmaniasis, Visceral; Parasitic Sensitivity Tests; Treatment Outcome

2012

Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection.

Journal of immunology (Baltimore, Md. : 1950), 2014, Oct-15, Volume: 193, Issue:8

Topics: Acetylation; Animals; Antibodies; Antimony; Antimony Sodium Gluconate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Cricetinae; Drug Resistance; Histone Deacetylase 6; Histone Deacetylases; Imipramine; Interleukin-10; Interleukin-12; Interleukin-12 Subunit p35; Interleukin-12 Subunit p40; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; NF-kappa B p50 Subunit; Promoter Regions, Genetic; Signal Transduction; T-Lymphocytes; Transcription Factor RelA; Trypanocidal Agents

2014